dc.contributor.author | De Giorgi, Riccardo | |
dc.date.accessioned | 2022-06-23T14:08:24Z | |
dc.date.available | 2022-06-23T14:08:24Z | |
dc.date.issued | 2022-02 | |
dc.identifier.citation | Riccardo De Giorgi. Ketamine for suicidal ideation: New trial challenges current thinking about ketamine. BMJ 2022;376:o74 | en |
dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1052 | |
dc.description | Open Access | en |
dc.description.abstract | Will ketamine be given to eligible patients with suicidal ideation
any time soon? This is hard to say, given the plausible concern that
the widespread use of ketamine might trigger a new opioid style
crisis.10 Whether ketamine reduces suicidal ideation in some people
is a matter of evidence
—which this trial by Abbar and colleagues
provides.
But whether the emergency use of ketamine for suicidal
crises will be recommended in practice depends on many other
factors, including the values and preferences of patients, clinicians,
researchers, and policymakers. | en |
dc.description.uri | https://doi.org/10.1136/bmj.o74 | en |
dc.language.iso | en | en |
dc.subject | Suicide | en |
dc.title | Ketamine for suicidal ideation: New trial challenges current thinking about ketamine | en |
dc.type | Article | en |
dc.contributor.discipline | Medical Trainee | en |